Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Meta and Apple team up to make Muse AI models run better on Macs

October 15, 2026

Calgary Stampeders need help to reach CFL playoffs

October 15, 2026

Flintstones vitamins, Aleve and Claritin tablets hit in new recall

October 15, 2026

Sony made a $5,900 gold-plated Walkman MP3 player

October 15, 2026

Fisheries sector fund gets $300 million extension from Ottawa, Atlantic provinces

October 15, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » U.S. Radiofrequency Ablation Devices Market to Hit USD 1.02 Billion by 2033 Amid Chronic Pain Rise
Press Release

U.S. Radiofrequency Ablation Devices Market to Hit USD 1.02 Billion by 2033 Amid Chronic Pain Rise

By News RoomJuly 3, 20263 Mins Read
U.S. Radiofrequency Ablation Devices Market to Hit USD 1.02 Billion by 2033 Amid Chronic Pain Rise
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, July 03, 2026 (GLOBE NEWSWIRE) — The “U.S. Radiofrequency Ablation Devices for Pain Management Market Size, Share & Trends Analysis Report by Product, End-Use, and Growth Forecasts, 2026-2033” has been added to ResearchAndMarkets.com’s offering.

The U.S. radiofrequency ablation (RFA) devices for pain management market is witnessing significant growth, with its size projected to escalate from USD 477.7 million in 2025 to USD 1.02 billion by 2033. Expected to grow at a CAGR of 10.1% from 2026 to 2033, this expansion is driven by an increasing prevalence of chronic pain conditions like arthritis and neuropathic disorders, coupled with a demand for minimally invasive, non-opioid pain treatments. The shift away from long-term opioid use further propels this trend.

Technological advancements in RFA, coupled with improved clinical outcomes and heightened awareness among patients and healthcare providers, are facilitating market expansion across the U.S. Nearly 24.3% of U.S. adults suffer from chronic pain, as per 2023 data from the Centers for Disease Control and Prevention, which emphasizes the need for advanced pain management solutions. RFA devices offer targeted relief, supporting the evolving clinical needs of a growing patient pool as it transitions from acute to chronic pain stages.

The increasing prevalence of chronic pain correlates with aging populations, sedentary lifestyles, obesity, and rising cases of musculoskeletal and neuropathic disorders. This demographic shift has escalated the demand for interventional procedures like RFA, which disrupts pain signals at the nerve level, reducing dependency on drugs. Chronic pain significantly affects over 21 million Americans, urging healthcare systems to prioritize effective management strategies that enhance quality of life. RFA devices, specifically designed for conditions such as osteoarthritis, spinal pain, and cancer-related pain, offer precise nerve ablation, driving their adoption in hospitals and outpatient settings.

U.S. Radiofrequency Ablation Devices For Pain Management Market Report Segmentation

This report provides a comprehensive analysis of the U.S. RFA devices for pain management market, forecasting revenue growth and examining industry trends from 2021 to 2033, segmented by product type and end-use.

Product Outlook (Revenue, USD Million, 2021-2033)

  • RFA Electrodes/Probes
  • Disposable
  • Reusable
  • RFA Cannula (or Needles)
  • RFA Generators
  • Others

End-use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals
  • Outpatient Facilities
  • Others

Reasons to Purchase This Report:

  • Comprehensive Market Analysis: Gain insights into the market across major regions and segments.
  • Competitive Landscape: Understand the market positioning of key players.
  • Future Trends: Discover key trends and drivers shaping the market’s future.
  • Actionable Recommendations: Leverage insights to tap into new revenue streams and inform strategic decisions.

The Report Offers:

  • Market intelligence for informed decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market evaluation
  • Competitive strategy and market share analysis
  • Product innovation listings to stay ahead

Key Attributes:

Report Attribute Details
No. of Pages 80
Forecast Period 2025 – 2033
Estimated Market Value (USD) in 2025 $477.7 Million
Forecasted Market Value (USD) by 2033 $1020 Million
Compound Annual Growth Rate 10.1%
Regions Covered United States

Companies Featured

  • Stryker Corporation
  • Abbott Laboratories
  • Medtronic plc
  • Boston Scientific Corporation
  • Avanos Medical, Inc
  • Epimed International, Inc.
  • Medline Inc.
  • Elevaris Medical Devices

For more information about this report visit https://www.researchandmarkets.com/r/m6ncq2

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • U.S. Radiofrequency Ablation Devices for Pain Management Market

            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

vineyard vines Returns as Official Style of the Head Of The Charles® Regatta

Bigger & Better Than Ever: Laxmi & Chef Kunal Kapur Return With ‘Diwali Delights’ Season 2

2026 Chery International User Summit to Kick Off: LUXEED Set for Global Brand Launch

Going Asset Management Wins Capital’s Excellence Fund Award, Harnessing Technology to Enhance the Long-Term Value of Assets

Alation Honors 2026 AI Radicals Award Winners at revAlation

Supported Employment: Helping Individuals Build Meaningful Careers

“The Carbon Pursuit of Happiness” Premieres October 10: A New Chapter for In-Depth Dialogue on Health and Humanity

Evolution Metals & Technologies Corp. Raises Fiscal 2026 Revenue Guidance 62% at Midpoint to 11 Million and Reaffirms 460 Million Fiscal 2027 Outlook

Ufunded Launches “Spotlight” Series, Documenting the Minds Shaping Modern Trading

Editors Picks

Calgary Stampeders need help to reach CFL playoffs

October 15, 2026

Flintstones vitamins, Aleve and Claritin tablets hit in new recall

October 15, 2026

Sony made a $5,900 gold-plated Walkman MP3 player

October 15, 2026

Fisheries sector fund gets $300 million extension from Ottawa, Atlantic provinces

October 15, 2026

Latest News

Friends don’t let friends feed their data to AI agents

October 15, 2026

As bond yields rise, how to pick between a variable or fixed rate mortgage?

October 15, 2026

Carney says he expects nations, including U.S., to stay out of Alberta vote

October 15, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version